Skip to main content

Search

Link to Facebook page Link to X Link to YouTube channel Link to Instagram Link to flipboard Link to RSS

Main navigation

Home
About
Video
Donate
Publications
Media/Contact
Subscribe
Write For Us

AT-527

email
facebook
twitter
linkedin
pocket
reddit
print

Roche's COVID Pill Disappoints. Is It Doomed?

Roche's COVID Pill Disappoints. Is It Doomed?

Atea Pharmaceuticals, which is (was?) co-developing another COVID antiviral drug with Roche called AT-527, issued a

Subscribe to AT-527

ACSH relies on donors like you. If you enjoy our work, please contribute.

Make your tax-deductible gift today!

Popular articles

There's no magic diet: The unpopular truth about nutrition

Out with “toxins,” in with “inflammation”: Inside the wellness industry’s favorite semantic trick

Are vegetables poison? ACSH tackles pesticide myths on Sactown Talks

Why are trial lawyers afraid of self-driving cars?

Yikes! There are pesticides in my berries!

ACSH Podcasts

Mom Pod Takeover: Demystifying the mammogram, and breaking down breast cancer myths, with Dr. Mansi Vaishnav

Mom Pod Takeover: Demystifying the mammogram, and breaking down breast cancer myths, with Dr. Mansi Vaishnav

Podcast: Be skeptical of health skeptics: When debunking goes too far

Mom Pod Takeover: Back-to-school health tips, vaccines, and flu season

Podcast: Marijuana legalization—fool's errand or good policy? Two doctors weigh in

Podcast: Time for accountability on COVID origins

Stay curious. Stay informed.

Free, independent writing delivered weekly. No ads, no sponsored fluff, and we never share or sell your data.

Always free. Never shared.

Footer

Privacy Policy
Contact us

COPYRIGHT © 1978-2026 BY THE AMERICAN COUNCIL ON SCIENCE AND HEALTH

Email: info@acsh.org
Phone: 301-980-4579

The American Council on Science and Health is a research and education organization operating under Section 501(c)(3) of the Internal Revenue Code. Contributions are fully tax-deductible. ACSH does not have an endowment. We raise our funds each year primarily from individuals and foundations.